Delivery Order SPE2DB22D2206-SPE2DB25FJA68
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,190.02 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical treatment commonly prescribed for osteoporosis management,...
- The Defense Logistics Agency awarded a $128,226.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Forteo (560 mcg/2.24 mL pen injections). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery is scheduled for completion by July 29, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a delivery order valued at $10,392.66 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 ml pen injections) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $20,336.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections), a pharmaceutical product used to treat osteoporosis. The contract was competitively awarded without set-aside designation and has an ultimate completion date of July 22, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency Troop Support Medical awarded a $25,086.79 firm fixed price delivery order to Amerisourcebergen Drug Corp for 4562119058, Forteo 600 mcg/2.4 ml pen injections. The delivery order is for 2.4 ml pen injections of Forteo to treat osteoporosis and will be fulfilled by Amerisourcebergen Drug Corp's Conshohocken, Pennsylvania facility by September 12, 2023 under the parent company Amerisourcebergen Corporation. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $10,405.72 delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The delivery order represents a single transaction under AmerisourceBergen Drug Corp's broader federal contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,601.43 to supply Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 31, 2025, and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,601.43 for Forteo (560 mcg/2.24 mL pen injection), a pharmaceutical product used in osteoporosis treatment. This firm fixed-price delivery order, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively procured with no...
- The Defense Logistics Agency awarded a delivery order valued at $62,529.46 to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections). This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,601.43 delivery order to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a pediatric pharmaceutical supply requirement fulfilled through competitive procurement with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA68Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,758.08 to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 mL pen injections. This firm fixed price delivery order was awarded competitively on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used in the treatment of osteoporosis and bone-related conditions. No set-aside designation was applied to this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor contract valued at $999,999,999.00 through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs and other federal healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capability in fulfilling federal medical procurement requirements through its extensive portfolio of competitive contract awards with the DLA Medical Supply Chain across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 7/23/25 |